applying molecular understanding of dlbcl to management strategies
Published 4 years ago • 52 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
1:52
an insight into the optimal management of patients with dlbcl
-
1:50
the importance of identifying patients with limited-stage dlbcl
-
0:43
the unmet need in dlbcl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
29:38
dlbcl treatment approaches: what you need to know
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
7:16
changes in the classification of dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
12:35
episode 1: role of quantitative radionuclide imaging in cardiac amyloidosis
-
1:45
improving the frontline treatment of dlbcl
-
1:56
the need for new treatment strategies for patients with dlbcl
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
2:19
italian perspective: managing dlbcl
-
1:05
identifying high-risk dlbcl and optimizing treatment for these patients
-
2:48
selecting between btk inhibitors in mcl & addressing resistance to these agents
-
4:01
first- and second-line treatment in dlbcl
-
14:40
update on the clinical management of diffuse large b-cell lymphoma
-
1:32
management and outcomes of elderly patients with lbcl
-
1:31
the current state of treatment for limited-stage dlbcl
-
1:33
the difficulties of mrd detection in dlbcl